← All trials
NCT02530619
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2015
- Primary completion
- Jul 1, 2017
- Completion date
- Mar 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 24
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Northwestern UniversityLead sponsor
- The Leukemia and Lymphoma SocietyCollaborator
- Millennium PharmaceuticalsCollaborator
- Northwestern UniversityOverall official - principal investigator
- Northwestern UniversityReponsible party - principal investigator
- National Cancer Institute (NCI)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.